253 related articles for article (PubMed ID: 37108638)
1. Upregulation of Inflammatory Mediators in Peripheral Blood CD40
Aldossari AA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Ayadhi LY; Alanazi MM; Shahid M; Alwetaid MY; Hussein MH; Ahmad SF
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108638
[TBL] [Abstract][Full Text] [Related]
2. DAPTA, a C-C chemokine receptor 5 (CCR5) antagonist attenuates immune aberrations by downregulating Th9/Th17 immune responses in BTBR T
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alotaibi MR; Alasmari AF; Alshammari MA; Al-Mazroua HA; Attia SM
Eur J Pharmacol; 2019 Mar; 846():100-108. PubMed ID: 30658114
[TBL] [Abstract][Full Text] [Related]
3. Adenosine A2A receptor modulates neuroimmune function through Th17/retinoid-related orphan receptor gamma t (RORγt) signaling in a BTBR T
Ansari MA; Nadeem A; Attia SM; Bakheet SA; Raish M; Ahmad SF
Cell Signal; 2017 Aug; 36():14-24. PubMed ID: 28438638
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alsaad AMS; Assiri MA; Al-Mazroua HA; Attia SM
J Neuroimmunol; 2020 Dec; 349():577430. PubMed ID: 33130460
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alotaibi MR; Alhoshani AR; Al-Hosaini KA; Attia SM
Int Immunopharmacol; 2018 Dec; 65():360-365. PubMed ID: 30380510
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CD45 cells in the development of autism spectrum disorder through dysregulation of granulocyte-macrophage colony-stimulating factor, key inflammatory cytokines, and transcription factors.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Alasmari AF; Alanazi MM; Al-Mazroua HA; Attia SM
Int Immunopharmacol; 2020 Jun; 83():106466. PubMed ID: 32259699
[TBL] [Abstract][Full Text] [Related]
7. Protection by tyrosine kinase inhibitor, tyrphostin AG126, through the suppression of IL-17A, RORγt, and T-bet signaling, in the BTBR mouse model of autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alshammari MA; Attia SM
Brain Res Bull; 2018 Sep; 142():328-337. PubMed ID: 30172736
[TBL] [Abstract][Full Text] [Related]
8. Cadmium Exposure Is Associated with Behavioral Deficits and Neuroimmune Dysfunction in BTBR T
Alanazi MM; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Aldossari AA; Almutairi MM; Albekairi TH; Hussein MH; Al-Hamamah MA; Ahmad SF
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047547
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of IL-9 and JAK-STAT signaling pathway in children with autism.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):472-480. PubMed ID: 28802860
[TBL] [Abstract][Full Text] [Related]
10. Oxidative and inflammatory mediators are upregulated in neutrophils of autistic children: Role of IL-17A receptor signaling.
Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Bakheet SA; Al-Harbi NO
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 90():204-211. PubMed ID: 30529000
[TBL] [Abstract][Full Text] [Related]
11. Imbalance in pro-inflammatory and anti-inflammatory cytokines milieu in B cells of children with autism.
Nadeem A; Ahmad SF; Al-Harbi NO; Al-Ayadhi LY; Sarawi W; Attia SM; Bakheet SA; Alqarni SA; Ali N; AsSobeai HM
Mol Immunol; 2022 Jan; 141():297-304. PubMed ID: 34915269
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation in IL-6 receptors is associated with upregulated IL-17A related signaling in CD4+ T cells of children with autism.
Nadeem A; Ahmad SF; Attia SM; Al-Ayadhi LY; Al-Harbi NO; Bakheet SA
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109783. PubMed ID: 31655158
[TBL] [Abstract][Full Text] [Related]
13. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of peripheral CXC and CC chemokine receptor expression on CD4
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():211-220. PubMed ID: 28986277
[TBL] [Abstract][Full Text] [Related]
15. Downregulation in Helios transcription factor signaling is associated with immune dysfunction in blood leukocytes of autistic children.
Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Al-Ayadhi LY; Attia SM
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jul; 85():98-104. PubMed ID: 29698674
[TBL] [Abstract][Full Text] [Related]
16. Alterations in Plasma Cytokine Levels in Korean Children with Autism Spectrum Disorder.
Shim S; Ha S; Choi J; Kwon HK; Cheon KA
Yonsei Med J; 2024 Feb; 65(2):70-77. PubMed ID: 38288647
[TBL] [Abstract][Full Text] [Related]
17. Methylmercury chloride exposure exacerbates existing neurobehavioral and immune dysfunctions in the BTBR T
Al-Mazroua HA; Nadeem A; Ansari MA; Attia SM; Albekairi TH; Bakheet SA; Alobaidi AF; Alhosaini K; Alqarni SA; Ibrahim KE; Alsaad AMS; Ahmad SF
Immunol Lett; 2022 Apr; 244():19-27. PubMed ID: 35259423
[TBL] [Abstract][Full Text] [Related]
18. Immunological characterization and transcription profiling of peripheral blood (PB) monocytes in children with autism spectrum disorders (ASD) and specific polysaccharide antibody deficiency (SPAD): case study.
Jyonouchi H; Geng L; Streck DL; Toruner GA
J Neuroinflammation; 2012 Jan; 9():4. PubMed ID: 22226452
[TBL] [Abstract][Full Text] [Related]
19. Elevated IL-16 expression is associated with development of immune dysfunction in children with autism.
Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Al-Ayadhi LY; Attia SM
Psychopharmacology (Berl); 2019 Feb; 236(2):831-838. PubMed ID: 30456538
[TBL] [Abstract][Full Text] [Related]
20. A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism.
Alomar HA; Ansari MA; Nadeem A; Attia SM; Bakheet SA; Al-Mazroua HA; Hussein MH; Alqarni SA; Ahmad SF
J Neuroimmunol; 2023 Apr; 377():578069. PubMed ID: 36931207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
